Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heart Failure New York Heart Association (NYHA) Class II”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Testing effectiveness (Phase 2)Study completedNCT05353166
What this trial is testing

REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge Pressure

Who this might be right for
Heart Failure
Regeneron Pharmaceuticals 59
Not applicableEnrolling By InvitationNCT05255172
What this trial is testing

Exercise Intervention in Patients With Heart Failure With Preserved and Reduced Ejection Fraction

Who this might be right for
Heart Failure New York Heart Association (NYHA) Class IIHeart Failure New York Heart Association (NYHA) Class III
Region Skane 120
Large-scale testing (Phase 3)Study completedNCT00232180
What this trial is testing

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines

Who this might be right for
Heart Failure
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2,743
Not applicableWithdrawnNCT03947853
What this trial is testing

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure

Who this might be right for
Heart FailureHeart Failure NYHA Class IIIHeart Failure NYHA Class II+1 more
Elpen Pharmaceutical Co. Inc.
Large-scale testing (Phase 3)Ended earlyNCT02656329
What this trial is testing

International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device

Who this might be right for
Heart Failure
GE Healthcare 395
Testing effectiveness (Phase 2)Study completedNCT00461058
What this trial is testing

A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 14
Testing effectiveness (Phase 2)Ended earlyNCT02625922
What this trial is testing

Study of the Effect of Serelaxin on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 26
Not applicableLooking for participantsNCT05934487
What this trial is testing

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure
Endotronix, Inc. 1,750